Inactive Instrument
Quotes VALBIOTIS Euronext Paris
Stocks
FR0013254851
Biotechnology & Medical Research
|
End-of-day quote
Euronext Paris
|
||
| - PTS | - |
|
| 07-22 | Valbiotis Publishes Results of Reverse-It Clinical Study Evaluating Totum 63 in Nature Communications | CI |
| 06-29 | Valbiotis Raises EUR10 Million for Commercial Development, Working Capital | MT |
Stock exchange
Euronext Paris- PTS
-
0
PTS
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ALVAL | 0.8060EUR | -0.25% | 224.87 € | ||
Deutsche Boerse AG
| 8JD | 0.7750EUR | -2.76% | 0 € | |
|
Börse Stuttgart
| 8JD | 0.7730EUR | +0.26% | 0 € | |
|
Boerse Muenchen
| 8JD | 0.8100EUR | 0.00% | 0 € | |
|
CBOE
| 0.7850EUR | 0.00% | 0 € | ||
|
CBOE
| 0.7850EUR | 0.00% | 0 € |
Basic data
Market Cap ($$$)
19,115,130
Market Cap (USD)
22,325,543
Net sales (EUR)
1,046,000
Net sales (USD)
1,221,677
Free-Float
97.31 %
Free-Float capitalization ($$$)
27,943,479
Free-Float capitalization (USD)
32,636,626
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 22.33M | |
| +2.38% | +3.43% | +82.88% | +115.89% | 73.96B | |
| -0.63% | +20.62% | +52.92% | +93.12% | 64.66B | |
| -4.27% | -0.99% | -3.38% | +475.61% | 27.32B | |
| -1.97% | +20.38% | -0.37% | +0.48% | 27.86B | |
| +2.34% | +12.43% | +62.04% | +27.51% | 25.97B | |
| -0.33% | +5.73% | +38.71% | -12.79% | 19.98B | |
| -1.79% | -4.84% | +239.54% | +414.48% | 17.84B | |
| +1.22% | +3.55% | +18.77% | +534.12% | 16.24B | |
| -1.29% | +6.09% | +41.81% | +154.45% | 13.3B | |
| Average | -0.49% | +6.18% | +59.21% | +200.32% | 28.72B | |
| Weighted average by Cap. | -0.02% | +8.21% | +59.10% | +160.84% |
Historical Quotes: VALBIOTIS
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- ALVAL Stock
- Stock
- Quotes VALBIOTIS
Select your edition
All financial news and data tailored to specific country editions
